Events

How can efforts to implement Antimicrobial Resistance National Action Plans still progress despite the COVID-19 pandemic? There is no doubt COVID-19 currently represents the most obvious and urgent issue for global health security and the world is rightfully focused on tackling this pandemic. However, the challenges posed by COVID-19 are only a foretaste of what […]

The Milken Institute Future of Health Summit convenes the best minds in the world to confront the most significant health challenges by matching human, financial, scientific, and educational resources with innovative and impactful ideas. The Summit will focus on the converging crises of public health, economic insecurity, and social injustice. COVID-19 has exposed weaknesses across […]

Join us at the virtual 2020 ASM Conference on Next-Generation Sequencing, taking place Dec. 7-11, 2020, and get comprehensive guidance with up-to-date examples in the use of NGS technology for applied results in the traceability and clustering of microbial pathogens associated with food safety, clinical infection, environmental contamination and other potential sources of disease outbreaks. […]

CARB-X participants include Erin Duffy, Chief of R&D. Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services, to form Blue Knight. This collaboration aims to stimulate innovation and incubation […]

The National Academy of Sciences (NAS) is a private, nonprofit organization of the country’s leading researchers. The NAS recognizes and promotes outstanding science through election to membership; publication in its journal, PNAS; and its awards, programs, and special activities. Through the National Academies of Sciences, Engineering, and Medicine, the NAS provides objective, science-based advice on […]

Immune modulation and host directed therapies as an adjunctive approach to treating infections (R.E.W. (Bob) Hancock): Host defence peptides (HDP; often termed antimicrobial peptides) stimulate protective immunity while suppressing potentially harmful inflammation. Both of these activities can assist in anti-infective therapy. HDPs work as immune modulators in animal models against ESKAPE pathogen, MDR TB, fungal, […]

Joint meeting with: The Microbiome: From Mother to Child January 18-20, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET* Our understanding of the microbiome is advancing rapidly, and continues to productively move through the discovery phase, with numerous correlations being established between specific commensal microbes or microbiota compositions and a wide range of diseases that […]

Antimicrobial resistance (AMR) is a major public health threat. Infections caused by resistant bacteria are increasing and causing Europe to face soaring costs both in terms of lives and public health expenditure. Despite the strong need for new antimicrobials, very few new, effective antibiotics have been brought to the market in the last decades. The […]

Please make plans to join us for this outstanding line-up of internationally-renowned experts in antimicrobial resistance and stewardship. Click here to learn more. Click here to view the agenda. Click here to register.

Participants include CARB-X funded companies Eligo Bioscience and Seres Therapeutics. As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target […]